Gynaecological Cancer

The King’s Health Partners Gynaecological Cancer Biobank was established in 2022 to collect tissue, blood, ascites, and comprehensive clinical data from patients at the time of initial diagnosis or relapse. The biobank focuses on malignant tissue from cancers of the female reproductive system, including ovarian, uterine, endometrial, and cervical cancers. Specimens are collected following surgical resections or biopsies conducted at Guy’s and St Thomas’ NHS Foundation Trust.

​

The primary aim of the Gynaecological Cancer Biobank is to provide researchers with high-quality biological samples, blood derivatives, and accompanying clinical and pathological data, enabling a deeper understanding of these cancers and facilitating the development of new treatments.

​

Applications to access the biobank’s samples or data are accepted from investigators in both academic and commercial sectors.